X2.0 will set up custom and needs based 5-month deeptech programme. The program will tailor its services to the needs of each startup, ensuring growth, scaling up, long term impact and cross border connections. Each selected startup will be screened by Venture Capital and Innovation experts and based on their insights, validated industry experts and their services will be proposed.
What are they looking for?
HealthTech & BioTech Call is open to all areas of both physical and mental health, including improvements to existing healthcare structures (human and veterinary) and all biotechnologies directly tied to service improvements and disease management. Startups that have innovative solutions including new diagnostics, devices, or therapy services to enable improved disease and infrastructure management, as well as the organization of care, are invited to apply.
More specifically, X2.0 is looking for HealthTech startups with solutions in the following: mobile health apps, electronic health and medical records, wearable devices (linked to health), telehealth and telemedicine, and management and IT software (linked to health). X2.0 is seeking startups that have a clear role in the areas of biopharmaceuticals, cell therapy, gene therapy and genome editing, antimicrobial resistance, pain and addiction, drug development, review and lifecycle management, rare diseases and orphan drugs, and vaccines and biodefense.
Why to participate / Benefits
Innovation Vouchers to cover
- Needs-based growth and scaling services in the max. amount of €20,000
- 1-on-1 mentorship with experts from the field of need in the min. amount of €5,000
- Access large-scale startup and investor-oriented events, exhibitions, and fairs in the amount of €5,000
Other Program Benefits
- Corporate Matchmaking and procurement
- Private Fundraising assistance
- Custom EU funding and public procurement ecosystem and overview
- Talent Matchmaking & Job promotion
- Promotion & Visibility
Key Dates
- Open Call: Start date: 04.07.2023 / End Date: 05.09.2023
- Evaluation: Start date: 06.09.2023 / End Date: 29.09.2023
- Growth programme: Start date: 01.11.2023 / End Date: 31.03.2024
- Evaluation: Start date: 06.09.2023 / End Date: 29.09.2023
More info: https://x2-0.eu/3rd-open-call-healthtech-biotech/
Do not hesitate to contact your EEN Health Advisor, Emilie Fonck for more information